Nishida Naoshi, Kudo Masatoshi
Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.
Front Oncol. 2020 Dec 21;10:594580. doi: 10.3389/fonc.2020.594580. eCollection 2020.
Recent advancement in artificial intelligence (AI) facilitate the development of AI-powered medical imaging including ultrasonography (US). However, overlooking or misdiagnosis of malignant lesions may result in serious consequences; the introduction of AI to the imaging modalities may be an ideal solution to prevent human error. For the development of AI for medical imaging, it is necessary to understand the characteristics of modalities on the context of task setting, required data sets, suitable AI algorism, and expected performance with clinical impact. Regarding the AI-aided US diagnosis, several attempts have been made to construct an image database and develop an AI-aided diagnosis system in the field of oncology. Regarding the diagnosis of liver tumors using US images, 4- or 5-class classifications, including the discrimination of hepatocellular carcinoma (HCC), metastatic tumors, hemangiomas, liver cysts, and focal nodular hyperplasia, have been reported using AI. Combination of radiomic approach with AI is also becoming a powerful tool for predicting the outcome in patients with HCC after treatment, indicating the potential of AI for applying personalized medical care. However, US images show high heterogeneity because of differences in conditions during the examination, and a variety of imaging parameters may affect the quality of images; such conditions may hamper the development of US-based AI. In this review, we summarized the development of AI in medical images with challenges to task setting, data curation, and focus on the application of AI for the managements of liver tumor, especially for US diagnosis.
人工智能(AI)的最新进展推动了包括超声检查(US)在内的人工智能驱动的医学成像技术的发展。然而,恶性病变的漏诊或误诊可能会导致严重后果;将人工智能引入成像模式可能是防止人为错误的理想解决方案。为了开发用于医学成像的人工智能,有必要在任务设置、所需数据集、合适的人工智能算法以及具有临床影响的预期性能等背景下了解成像模式的特征。关于人工智能辅助的超声诊断,已经在肿瘤学领域进行了多项尝试,以构建图像数据库并开发人工智能辅助诊断系统。关于使用超声图像诊断肝脏肿瘤,已有报道使用人工智能进行4类或5类分类,包括区分肝细胞癌(HCC)、转移性肿瘤、肝血管瘤、肝囊肿和局灶性结节性增生。将放射组学方法与人工智能相结合也正在成为预测HCC患者治疗后预后的有力工具,这表明人工智能在应用个性化医疗方面的潜力。然而,由于检查期间条件的差异,超声图像显示出高度的异质性,并且各种成像参数可能会影响图像质量;这些情况可能会阻碍基于超声的人工智能的发展。在本综述中,我们总结了医学图像中人工智能的发展,以及在任务设置、数据管理方面面临的挑战,并重点关注人工智能在肝脏肿瘤管理中的应用,特别是在超声诊断方面。